Metraipolis › archive › dc_1adf30bec8cd

Development and validation of a machine learning-based predictive model for clinical remission in Crohn's disease patients receiving Adalimumab therapy — Europe PMC PMID:40971365

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40971365
DOI
10.1371/journal.pone.0331447
License (as archived)
solo-consultazione
Archived
2026-11-09T20:35:31.005Z
SHA-256 of the archived text
c079a44e6d021785e6af4d292484a34391b3b7c269bcb2bcc70934525f113467
Stable URL of this page
https://metraipolis.com/documento/dc_1adf30bec8cd

How to cite

Development and validation of a machine learning-based predictive model for clinical remission in Crohn's disease patients receiving Adalimumab therapy — Europe PMC PMID:40971365 — Europe PMC (en), https://europepmc.org/article/MED/40971365 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1adf30bec8cd (Metraipolis archive dc_1adf30bec8cd, sha256 c079a44e6d021785e6af4d292484a34391b3b7c269bcb2bcc70934525f113467)
BibTeX
@misc{dc1adf30bec8cd,
  title = {Development and validation of a machine learning-based predictive model for clinical remission in Crohn's disease patients receiving Adalimumab therapy — Europe PMC PMID:40971365},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40971365},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1adf30bec8cd; sha256 c079a44e6d021785e6af4d292484a34391b3b7c269bcb2bcc70934525f113467},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40971365. Agents can read the archived copy with the MCP tool read_document.